Skip to main content

D. E. Shaw & Co., Inc.

Position in CAPR — Capricor Therapeutics, Inc.

CIK 1009207 New York, NY

Position in CAPR

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,979,802
+$2,979,802 QoQ
Shares Held
123,746
Ownership
0.213%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#38
of 169 holders
Holding Since
Dec 2024
6 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CAPR Over Time

Shares Held

Position Value (USD)

Derivatives in CAPR

reported options exposure · as of Jun 30, 2026
CallValue
$7,585,200
CallShares
315,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

D. E. Shaw & Co., Inc. holds $5,017,559,982 across 217 Biotechnology names. CAPR ranks #115 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CAPR

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,979,802 123,746
2026-06-30 $7,585,200 315,000
2026-03-31 $9,576,000 315,000
2025-12-31 $9,090,900 315,000
2025-09-30 $468,650 65,000
2025-09-30 $114,963 15,945
2025-06-30 $106,578 10,733
2024-12-31 $741,529 53,734